A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.

Clinical trial NCT03755102 · COMPLETED

Trial details

NCT number: NCT03755102
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

EGFR Gene Mutation Lung Cancer Lung Cancer Metastatic

Start date: 2018-11-21
Primary completion: 2023-07-07
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.